Showing results (251-260 of 358) with videos related to

Sort By:
Pageof 36
Alzheimer Disease and Associated Disorders|June 8, 2001
The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer diseaseH Feldman, A Sauter, A Donald, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 10, 2001
Assessment of suspected dementiaH Chertkow, H Bergman, H M Schipper, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6)T Erkinjuntti, S Gauthier, R Bullock, et al.
Neurology|October 27, 1997
Sleep and quantitative EEG in patients with progressive supranuclear palsyJ Montplaisir, D Petit, A Décary, et al.
Neurology|July 1, 1984
Enzyme changes in actively spiking areas of human epileptic cerebral cortexA Sherwin, F Quesney, S Gauthier, et al.
Trends in Pharmacological Sciences|December 1, 1989
Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's diseaseR Quirion, I Aubert, P A Lapchak, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational StudyK Kahle-Wrobleski, J S Andrews, M Belger, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 26, 1998
Ethical guidelines of the Alzheimer Society of CanadaJ D Fisk, A D Sadovnick, C A Cohen, et al.
Pageof 36